BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6940834)

  • 1. Endotoxin enhanced adjuvant effect of liposomes, particularly when antigen and endotoxin are incorporated within the same liposome.
    van Rooijen N; van Nieuwmegen R
    Immunol Commun; 1980; 9(8):747-57. PubMed ID: 6940834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes in immunology: impairment of the adjuvant effect of liposomes by incorporation of the adjuvant lysolecithin and the role of macrophages.
    van Rooijen N; van Nieuwmegen R
    Immunol Commun; 1979; 8(4):381-96. PubMed ID: 489057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The secondary immune response against liposome associated antigens.
    van Rooijen N; van Nieuwmegen R; Kors N
    Immunol Commun; 1981; 10(1):59-70. PubMed ID: 7275167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes in immunology: further evidence for the adjuvant activity of liposomes.
    van Rooijen N; van Nieuwmegen R
    Immunol Commun; 1978; 7(6):635-44. PubMed ID: 84783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of macrophages in the immunoadjuvant action of liposomes: effects of elimination of splenic macrophages on the immune response against intravenously injected liposome-associated albumin antigen.
    Su D; Van Rooijen N
    Immunology; 1989 Mar; 66(3):466-70. PubMed ID: 2703258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-15 acts as an immunological co-adjuvant for liposomal antigen in vivo.
    Gursel M; Gregoriadis G
    Immunol Lett; 1997 Mar; 55(3):161-5. PubMed ID: 9161882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant effects of nonionic block polymer surfactants on liposome-induced humoral immune response.
    Zigterman GJ; Snippe H; Jansze M; Willers JM
    J Immunol; 1987 Jan; 138(1):220-5. PubMed ID: 3782798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes in immunology: the immune response against antigen-containing liposomes.
    van Rooijen N; van Nieuwmegen R
    Immunol Commun; 1977; 6(5):489-98. PubMed ID: 924513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The primary immune response in mice. I. The enhancement and suppression of hemolysin production by a bacterial endotoxin.
    Franzl RE; McMaster PD
    J Exp Med; 1968 Jun; 127(6):1087-107. PubMed ID: 5653220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of surface-coupled antigen of liposomes in immunopotentiation.
    Latif NA; Bachhawat BK
    Immunol Lett; 1987 May; 15(1):45-51. PubMed ID: 3610232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomes with differential lipid components exert differential adjuvanticity in antigen-liposome conjugates via differential recognition by macrophages.
    Tanaka Y; Kasai M; Taneichi M; Naito S; Kato H; Mori M; Nishida M; Maekawa N; Yamamura H; Komuro K; Uchida T
    Bioconjug Chem; 2004; 15(1):35-40. PubMed ID: 14733581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes.
    Korsholm KS; Agger EM; Foged C; Christensen D; Dietrich J; Andersen CS; Geisler C; Andersen P
    Immunology; 2007 Jun; 121(2):216-26. PubMed ID: 17302734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adjuvant effect of liposomes in eliciting anti-galactosyl antibodies.
    Sarkar DP; Das PK; Bachhawat BK; Das MK
    Immunol Commun; 1982; 11(3):175-88. PubMed ID: 7141461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier and adjuvant properties of liposome-borne tumor-specific antigens.
    LeGrue SJ
    Cancer Immunol Immunother; 1984; 17(2):135-41. PubMed ID: 6565518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An increased adjuvanticity of liposomes by the inclusion of phosphatidylserine in immunization with surface-coupled liposomal antigen.
    Mori M; Nishida M; Maekawa N; Yamamura H; Tanaka Y; Kasai M; Taneichi M; Uchida T
    Int Arch Allergy Immunol; 2005 Jan; 136(1):83-9. PubMed ID: 15591816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes in immunology: multilamellar phosphatidylcholine liposomes as a simple, biodegradable and harmless adjuvant without any immunogenic activity of its own.
    van Rooijen N; van Nieuwmegen R
    Immunol Commun; 1980; 9(3):243-56. PubMed ID: 7399568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomes as vehicles for vaccines.
    Alving CR; Banerji B; Shiba T; Kotani S; Clements JD; Richards RL
    Prog Clin Biol Res; 1980; 47():339-55. PubMed ID: 7208512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response mediated by liposome-associated protein antigens. II. Comparison of the effectiveness of vesicle-entrapped and surface-associated antigen in immunopotentiation.
    Shek PN; Sabiston BH
    Immunology; 1982 Dec; 47(4):627-32. PubMed ID: 6754583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic DDA/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity.
    Qu W; Li N; Yu R; Zuo W; Fu T; Fei W; Hou Y; Liu Y; Yang J
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):852-860. PubMed ID: 29447484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.